EMERGENT BIOSOLUTIONS INC. Restructuring and Related Cost, Number of Positions Eliminated
EMERGENT BIOSOLUTIONS INC. (EBS) reported Restructuring and Related Cost, Number of Positions Eliminated of 14 Employee for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2015-03-09
- EMERGENT BIOSOLUTIONS INC. restructuring and related cost, number of positions eliminated for fiscal 2014 was 14.00 Employee, a 0.00% change from fiscal 2013.
- EMERGENT BIOSOLUTIONS INC. restructuring and related cost, number of positions eliminated for fiscal 2013 was 14.00 Employee.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 12 month |
|---|---|
| 2014-12-31 | 14.00 Employee 10-K · filed 2015-03-09 |
| 2013-12-31 | 14.00 Employee 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |